PRKAG1 and hepatocellular carcinoma: Results showed that cell cycle (e.g., G2/M checkpoint) and mitosis-related pathways were significantly activated in the high PRKAG1 expression group (Figure 5I), implying that PRKAG1 may drive HCC proliferation by promoting cell cycle progression.